Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.26), in-line with the analyst estimate of ($0.26).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
• Barclays Upgrades Legrand SA (LR:FP) (LGRDY) to Overweight
• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside